Skip to content

003850.KS

Boryung Corporation

KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR

KRW 8,900.00
+0.45%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue1060.3B1017.4B1017.1B859.6B760.5B
Cost of Revenue690.1B664.9B653.7B506.2B453.3B
Gross Profit365.3B352.5B363.4B353.4B307.2B
Operating Expenses
R&D Expense47.7B65.1B51.5B47.3B41.7B
SG&A Expense129.8B99.6B99.1B92.1B92.0B
General & Admin Expense17.9B20.7B21.3B19.2B17.9B
Selling & Marketing Expense78.1B78.8B77.7B72.8B74.2B
Other Expenses134.3B122.8B142.3B145.8B116.9B
Total Operating Expenses292.5B287.4B292.9B285.2B250.6B
Cost and Expenses987.6B950.5B946.6B791.9B703.9B
Operating Income (EBIT)72.7B65.1B70.5B68.3B56.6B
Non-Operating
Interest Income12.4B8.6B6.0B871.8M4.5B
Interest Expense13.2B11.6B9.0B9.5B6.1B
Net Interest Income(841.2M)(3.0B)(3.0B)(8.7B)(1.6B)
Other Non-Op Income/Expense75.0B4.8B(7.5B)(12.0B)2.3B
Non-Operating Income (excl Interest)(40.8B)(16.4B)(1.5B)2.4B(12.6B)
EBT (Pre-Tax Income)147.7B69.8B63.0B56.3B58.9B
Income Tax Expense27.1B5.5B(6.7B)16.1B16.9B
Bottom Line
Net Income120.6B64.3B69.6B40.2B41.9B
Earnings from Cont. Ops120.6B64.3B69.6B40.2B41.9B
Earnings from Discont. Ops
Bottom Line Net Income120.6B64.3B69.6B40.2B41.9B
Per Share
Basic EPS₩1,436₩766₩1,020₩610₩636
Diluted EPS₩1,435₩766₩1,016₩610₩634
Revenue Per Share₩12,360₩12,120₩14,894₩13,051₩11,543
Shares
Basic Shares Outstanding85.8M83.9M68.3M65.9M65.9M
Diluted Shares Outstanding85.8M83.9M68.5M65.9M66.1M
Profitability Metrics
EBITDA137.2B108.6B114.8B110.2B105.7B
D&A47.4B43.5B42.8B44.4B36.6B
EBIT90.0B65.1B72.0B65.9B69.2B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026